SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 44.39 |
| Enterprise Value ($M) | 28.89 |
| Book Value ($M) | 58.53 |
| Book Value / Share | 1.54 |
| Price / Book | 0.76 |
| NCAV ($M) | 39.95 |
| NCAV / Share | 1.05 |
| Price / NCAV | 1.11 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.49 |
| Return on Assets (ROA) | -0.25 |
| Return on Equity (ROE) | -0.40 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.13 |
| Current Ratio | 3.13 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 80.46 |
| Assets | 99.04 |
| Liabilities | 40.51 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Avidity Partners Management LP | 9.90 | 1.75 | |
| 13G/A | Federated Hermes, Inc. | 17.22 | 0.00 | |
| 13G/A | Caxton Corp | 0.00 | -100.00 | |
| 13G/A | Stonepine Capital Management, LLC | 3.60 | -51.22 | |
| 13G/A | Kingdon Capital Management, L.l.c. | 6.02 | 31.82 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 18,359 | 114,979 | 15.97 | |
| 45,131 | 180,839 | 24.96 | |
| 53,344 | 221,922 | 24.04 | |
| 59,633 | 197,325 | 30.22 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| RVNC – Revance Therapeutics, Inc. | RYTM – Rhythm Pharmaceuticals, Inc. |
| SAGE – Sage Therapeutics, Inc. | SGMT – Sagimet Biosciences Inc. |
| SIGA – SIGA Technologies, Inc. |